Citations (27)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Ananyaa Agrawal, Pratibha Chanana, Vikas Yadav, Vilakshan Bhutani, Naidu Subbarao & Aradhana Srivastava. (2023) Vitamin derivatives as potential drugs for Influenza Hemagglutinin. Journal of Biomolecular Structure and Dynamics 41:21, pages 11781-11795.
Read now
Read now
Woo-Jin Shin, Seongil Choi & Baik-Lin Seong. (2023) What are the considerations when selecting a model for influenza drug discovery?. Expert Opinion on Drug Discovery 18:1, pages 1-3.
Read now
Read now
Articles from other publishers (25)
Tianxin Ma, Shiqi Niu, Zihua Wu, Shenghui Pan, Chenyang Wang, Xiaona Shi, Minghao Yan, Bangfeng Xu, Xingpo Liu, Luzhao Li, Dawei Yan, Qiaoyang Teng, Chunxiu Yuan, Xue Pan, Zhifei Zhang, Hoang Minh Duc, Zejun Li & Qinfang Liu. (2023) Genome-wide CRISPR screen identifies GNE as a key host factor that promotes influenza A virus adsorption and endocytosis. Microbiology Spectrum.
Crossref
Crossref
Umme Laila Urmi, Ajay Kumar Vijay, Rajesh Kuppusamy, Salequl Islam & Mark D.P. Willcox. (2023) A review of the antiviral activity of cationic antimicrobial peptides. Peptides 166, pages 171024.
Crossref
Crossref
Hamieh Goshtasbi, Yuri B. Okolodkov, Ali Movafeghi, Suresh Awale, Azam Safary, Jaleh Barar & Yadollah Omidi. (2023) Harnessing microalgae as sustainable cellular factories for biopharmaceutical production. Algal Research 74, pages 103237.
Crossref
Crossref
Johan Vingerhoets, Ilse Van Dromme, Wilbert van Duijnhoven, David Anderson, Sandra De Meyer & Lorant Leopold. (2023) Genotypic and phenotypic characterization of influenza A viral variants in study participants treated with pimodivir in the phase 2b TOPAZ study. Antiviral Therapy 28:3, pages 135965352311742.
Crossref
Crossref
Yi-Ju Han, Kuo-Ming Lee, Guan-Hong Wu, Yu-Nong Gong, Avijit Dutta & Shin-Ru Shih. (2023) Targeting influenza A virus by splicing inhibitor herboxidiene reveals the importance of subtype-specific signatures around splice sites. Journal of Biomedical Science 30:1.
Crossref
Crossref
Jayashree Seema Nandi. 2023. Global Perspectives on the Transmission of Zoonotic RNA Viruses from Wild Animal Species to Humans. Global Perspectives on the Transmission of Zoonotic RNA Viruses from Wild Animal Species to Humans
89
95
.
Lingxin Hou, Ying Zhang, Han Ju, Srinivasulu Cherukupalli, Ruifang Jia, Jian Zhang, Bing Huang, Arianna Loregian, Xinyong Liu & Peng Zhan. (2022) Contemporary medicinal chemistry strategies for the discovery and optimization of influenza inhibitors targeting vRNP constituent proteins. Acta Pharmaceutica Sinica B 12:4, pages 1805-1824.
Crossref
Crossref
Olga Kurskaya, Elena Prokopyeva, Hongtao Bi, Ivan Sobolev, Tatyana Murashkina, Alexander Shestopalov, Lixin Wei & Kirill Sharshov. (2022) Anti-Influenza Activity of Medicinal Material Extracts from Qinghai–Tibet Plateau. Viruses 14:2, pages 360.
Crossref
Crossref
Yun Kim, Sangwon Lee, Yohan Kim, In‐Jin Jang & SeungHwan Lee. (2021) Pharmacokinetics and safety of a novel influenza treatment (baloxavir marboxil) in Korean subjects compared with Japanese subjects. Clinical and Translational Science 15:2, pages 422-432.
Crossref
Crossref
Yu‐Na Lee, Dong‐Hun Lee, Jae‐In Shin, Young‐Jae Si, Ji‐Ho Lee, Yoon‐Gi Baek, Seo Yun Hong, Seng Bunnary, Sothyra Tum, Minji Park, Soo‐Jeong Kye, Myoung‐Heon Lee & Youn‐Jeong Lee. (2021) Pathogenesis and genetic characteristics of a novel reassortant low pathogenic avian influenza A(H7N6) virus isolated in Cambodia in 2019. Transboundary and Emerging Diseases 68:6, pages 3180-3186.
Crossref
Crossref
Holly Everest, Elizabeth Billington, Rebecca Daines, Alice Burman & Munir Iqbal. (2021) The Emergence and Zoonotic Transmission of H10Nx Avian Influenza Virus Infections. mBio 12:5.
Crossref
Crossref
Md. Golzar Hossain, Sharmin Akter, Priya Dhole, Sukumar Saha, Taheruzzaman Kazi, Abir Majbauddin & Md. Sayeedul Islam. (2021) Analysis of the Genetic Diversity Associated With the Drug Resistance and Pathogenicity of Influenza A Virus Isolated in Bangladesh From 2002 to 2019. Frontiers in Microbiology 12.
Crossref
Crossref
Jacqueline Aparecida Takahashi, Bianca Vianna Rodrigues Barbosa, Matheus Thomaz Nogueira Silva Lima, Patrícia Gomes Cardoso, Christiane Contigli & Lúcia Pinheiro Santos Pimenta. (2021) Antiviral fungal metabolites and some insights into their contribution to the current COVID-19 pandemic. Bioorganic & Medicinal Chemistry 46, pages 116366.
Crossref
Crossref
Yue Ma, Estrella Frutos-Beltrán, Dongwei Kang, Christophe Pannecouque, Erik De Clercq, Luis Menéndez-Arias, Xinyong Liu & Peng Zhan. (2021) Medicinal chemistry strategies for discovering antivirals effective against drug-resistant viruses. Chemical Society Reviews 50:7, pages 4514-4540.
Crossref
Crossref
Yuxin Fu, Ate H. Jaarsma & Oscar P. Kuipers. (2021) Antiviral activities and applications of ribosomally synthesized and post-translationally modified peptides (RiPPs). Cellular and Molecular Life Sciences 78:8, pages 3921-3940.
Crossref
Crossref
Bo Han, Xiang-Hong He, Yan-Qing Liu, Gu He, Cheng Peng & Jun-Long Li. (2021) Asymmetric organocatalysis: an enabling technology for medicinal chemistry. Chemical Society Reviews 50:3, pages 1522-1586.
Crossref
Crossref
Hershna Patel & Andreas Kukol. (2021) Integrating molecular modelling methods to advance influenza A virus drug discovery. Drug Discovery Today 26:2, pages 503-510.
Crossref
Crossref
Shamaila Kausar, Fahad Said Khan, Muhammad Ishaq Mujeeb Ur Rehman, Muhammad Akram, Muhammad Riaz, Ghulam Rasool, Abdul Hamid Khan, Iqra Saleem, Saba Shamim & Arif Malik. (2021) A review: Mechanism of action of antiviral drugs. International Journal of Immunopathology and Pharmacology 35, pages 205873842110026.
Crossref
Crossref
Xiao-huan Liu, Xiao Zhang, Zhen-hua Lu, You-shuang Zhu & Tao Wang. (2021) Potential molecular targets of nonstructural proteins for the development of antiviral drugs against SARS-CoV-2 infection. Biomedicine & Pharmacotherapy 133, pages 111035.
Crossref
Crossref
Helen Bridle. 2021. Waterborne Pathogens. Waterborne Pathogens
9
40
.
Ana Vazquez-Pagan, Rebekah Honce & Stacey Schultz-Cherry. (2020) Impact of influenza virus during pregnancy: from disease severity to vaccine efficacy. Future Virology 15:7, pages 441-453.
Crossref
Crossref
Julita Piasecka, Elzbieta Lenartowicz, Marta Soszynska-Jozwiak, Barbara Szutkowska, Ryszard Kierzek & Elzbieta Kierzek. (2020) RNA Secondary Structure Motifs of the Influenza A Virus as Targets for siRNA-Mediated RNA Interference. Molecular Therapy - Nucleic Acids 19, pages 627-642.
Crossref
Crossref
Ling Li, Yi Ning, Ke Wei, Jue Hu, Tao Wu, Cheng Zhao, Fang-Guo Lu & Qing-Hu He. (2020) Study on the inhibition of PLD on IAV-induced pulmonary macrophage based on autophagy and apoptosis. Pharmacognosy Magazine 16:67, pages 132.
Crossref
Crossref
Felipe Tapia, Tanja Laske, Milena A. Wasik, Markus Rammhold, Yvonne Genzel & Udo Reichl. (2019) Production of Defective Interfering Particles of Influenza A Virus in Parallel Continuous Cultures at Two Residence Times—Insights From qPCR Measurements and Viral Dynamics Modeling. Frontiers in Bioengineering and Biotechnology 7.
Crossref
Crossref
Rebekah Honce & Stacey Schultz-Cherry. (2019) Impact of Obesity on Influenza A Virus Pathogenesis, Immune Response, and Evolution. Frontiers in Immunology 10.
Crossref
Crossref